Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lu Wang"'
Autor:
Zhao-You Tang, Peng-Yuan Zhuang, Ling-Qun Kong, Hui-Chuan Sun, Xiao-Dong Zhu, Lu Wang, Wei-Dong Jia, Wei-Zhong Wu, Ju-Bo Zhang, Yong-Bing Qian
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 439 (2012)
BMC Cancer
BMC Cancer
Background Postoperative interferon-α(IFN-α) treatment delays hepatocellular carcinoma(HCC) recurrence and prolongs patient survival, and may thus be an effective form of adjuvant therapy. However, clinical observations found that HCC recurs in som
Autor:
Jia Fan, Wei Wei Li, Lu Wang, Zhong Hua Tao, Jin Liang Wan, Lin Guo, Wei Zhong Wu, Zhao-You Tang, Hui-Chuan Sun, Chun Li Xiao
Publikováno v:
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 150 (2011)
BMC Cancer, Vol 11, Iss 1, p 150 (2011)
Background Hepatocellular carcinoma (HCC) usually has a dismal prognosis because of its limited response to current pharmacotherapy and high metastatic rate. Sulfated oligosaccharide has been confirmed as having potent antitumor activities against so
Autor:
Wei-Zhong Wu, Pei-li Fan, Hua-Xiang Xu, Ju-Bo Zhang, Yuquan Xiong, Peng-Yuan Zhuang, Zhao-You Tang, Hui-Chuan Sun, Ling-Qun Kong, Dong-Mei Gao, Hong Ding, Wei Zhang, Xiao-Dong Zhu, Lu Wang
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 28 (2011)
BMC Cancer
BMC Cancer
Background Antiangiogenesis is a promising therapy for advanced hepatocellular carcinoma (HCC), but the effects are difficult to be evaluated. Pazopanib (GW786034B) is a pan-vascular endothelial growth factor receptor inhibitor, the antitumor effects
Autor:
Yong-Hua Xu, Xinyu Huang, Zhao-You Tang, Lu Wang, Qi Zheng, Xiu-Yan Huang, Kaixing Ai, Zi-Li Huang
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 580 (2010)
BMC Cancer
BMC Cancer
Background Liver resection is a widely accepted treatment for hepatocellular carcinoma (HCC). Our previous clinical study showed that the rate of palliative resection was 34.0% (1958-2008, 2754 of 8107). However, the influence of palliative resection
Autor:
Shuang Liu, Miao Wang, Liu Zeyang, Xin Wang, Di-Hua Zhan, Lu Wang, Ning Zhang, De-Ning Ma, Jiamin Zhou, Yiming Zhao, Qi Pan, Weiping Zhu, Xigan He, Longrong Wang
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-13 (2016)
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-13 (2016)
Background Monoacylglycerol lipase (MAGL), a critical lipolytic enzyme, has emerged as a key regulator of tumor progression, yet its biological function and clinical significance in hepatocellular carcinoma (HCC) is still unknown. Methods In this stu